Serplulimab Combined With CCRT for LS-SCLC.
Conditions: Small Cell Lung Cancer Interventions: Drug: Serplulimab Sponsors: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Lung Cancer Screening by Artificial Intelligence Device
Conditions: Lung Cancer Interventions: Device: Lung-SIGHT Sponsors: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21)
Conditions: Non-small Cell Lung Cancer Interventions: Drug: DZD9008+AZD4205 Sponsors: Dizal Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
TGRX-326 Drug-Drug Interaction Pharmacokinetic Study
Conditions: Non Small Cell Lung Cancer Interventions: Drug: Itraconazole+TGRX-326; Drug: Efavirenz+TGRX-326 Sponsors: Shenzhen TargetRx, Inc.; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan
Conditions: Lung Cancer, Nonsmall Cell; Lung Cancer; Smoking Cessation; Lung Cancer, Small Cell Interventions: Radiation: Low-dose CT scan; Behavioral: Smoking Cessation Sponsors: University Hospital, Antwerp; Universiteit Antwerpen; Belgian Cancer Registry Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
Toripalimab Combined With SBRT for NSCLC
Conditions: Non-small Lung Cancer Interventions: Drug: Group A; Drug: Group B Sponsors: Shanghai Pulmonary Hospital, Shanghai, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness
Conditions: Lung Cancer Interventions: Drug: Immunotherapy Sponsors: Sun Yat-sen University; Jiangmen Central Hospital; Henan Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Conditions: Extensive Stage Lung Small Cell Carcinoma; Stage IV Lung Cancer AJCC v8 Interventions: Biological: Atezolizumab; Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Biological: Durvalumab; Procedure: Echocardiography; Drug: Iadademstat; Procedure: Magnetic Resonance Imaging; Procedure: Multigated Acquisition Scan Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC
Conditions: EGF-R Positive Non-Small Cell Lung Cancer Interventions: Other: ctDNA monitoring Sponsors: Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community
Conditions: Tobacco Dependence Interventions: Behavioral: C-Raven Virtual Tobacco Cessation Counseling; Drug: Nicotine Replacement Product; Other: Community Health Worker; Other: Lung Cancer Screening Sponsors: Johns Hopkins University; Maryland Cigarette Restitution Fund Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway
Conditions: Advanced Solid Tumor; RAF Mutation; RAS Mutation; NF1 Mutation; Non-Small Cell Lung Cancer; Pancreatic Ductal Adenocarcinoma; Melanoma; BRAF Gene Mutation; CRAF Gene Mutation Interventions: Drug: DCC-3084 Sponsors: Deciphera Pharmaceuticals LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer
Conditions: Locally Advanced Non-small Cell Lung Cancer Interventions: Radiation: concurrent or sequential chemoradiotherapy; Drug: Immunotherapy Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Using Infrared Spectroscopy to Analyze Volatile Organic Compounds (VOCs) in the Breath of Patients With Lung Cancer
Conditions: Lung Cancer; Non Small Cell Lung Cancer Sponsors: Picomole Inc; Vitalite Health Network Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
HA-WBRT-SIB for Brain Metastasis of Lung Cancer
Conditions: Lung Neoplasm; Brain Metastases; Simultaneous Integrated Boost; Hippocampal Avoidance; Cognitive Function Interventions: Radiation: HA-WBRT-SIB Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Study protocol: a core outcome set for perioperative exercise clinical effectiveness trials for lung cancer patients
This study protocol describes the methodology, aiming to develop a core outcome set for perioperative exercise intervention trials for lung cancer in clinical practice.MethodsThe project will follow the standard methodology recommended by the Core Outcome Measures in Effectiveness Trials (COMET) initiative, which is divided into four steps. Stage I: Conducting a scoping review of outcomes reported in clinical trials and protocols to develop a list of potential outcome domains. Stage II: Conducting semi-structured interviews to obtain important outcomes for patients. Stage III: Choosing the most important outcomes by conduc...
Source: Trials - March 1, 2024 Category: Research Source Type: clinical trials
